Intas Pharmaceuticals Limited Diltiazem Export Data — India (DGFT 2022–2026)

Name: Intas Pharmaceuticals Limited Diltiazem Export Records India — #4 Exporter, 26 Shipments, $1.3M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Diltiazem

India Pharmaceutical Trade Intelligence

$18.0M184 Suppliers71 CountriesHS 30049079

ExportsIndia → UNITED STATES62.4%India → CANADA18.8%

ImportsUNITED KINGDOM → India$760.0K UNITED STATES → India$155.5K

#1 Supplier: EMCURE PHARMACEUTICALS #1 Buyer: EVERSANA LIFE

Intas Pharmaceuticals Limited — Diltiazem Exporter #4 | $1.3M Trade Value | TransData Nexus | TransData Nexus

Intas Pharmaceuticals Limited — Diltiazem Exporter Profile

Indian Pharmaceutical Exporter · #4 for Diltiazem · $1.3M export value · DGFT Verified

Intas Pharmaceuticals Limited is the #4 Indian exporter of Diltiazem with $1.3M in export value and 26 verified shipments. Intas Pharmaceuticals Limited holds a 7.2% market share in Diltiazem exports across 1 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.

Intas Pharmaceuticals Limited — Diltiazem Export Profile: Buyers & Destinations

Intas Pharmaceuticals Limited Diltiazem export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Diltiazem?

Country	Value	Shipments	Share
UNITED STATES	$10.3M	207	61.3%
CANADA	$3.4M	133	20.1%
SRI LANKA	$1.6M	85	9.4%
UNITED ARAB EMIRATES	$555.9K	206

Who Are the Top Buyers of Diltiazem from India?

Buyer	Country	Value	Orders
EVERSANA LIFE SCIENCE SERVICES	UNITED STATES	$2.3M	47
MARCAN PHARMACEUTICALS INC.	CANADA	$1.6M	57
TEVA PHARMACEUTICALS USA, INC	UNITED STATES	$1.4M	27
EVERSANA LIFE SCIENCES SERVICES,LLC	UNITED STATES	$1.1M	22
MARCAN PHARMACEUTICALS INC.,	CANADA	$1.0M	40
MARCAN PHARMACEUTICALS INC	CANADA	$700.5K	27
MYLAN PHARMACEUTICALS INC	UNITED STATES	$686.9K	18
EUGIA US LLC	UNITED STATES	$450.0K	9
EVERSANA LIFESCIENCE SERVICES	UNITED STATES	$400.0K	8
J. KNIPPER & COMPANY	UNITED STATES	$250.0K	5

India's Diltiazem is purchased by 298 buyers worldwide. The top buyer is EVERSANA LIFE SCIENCE SERVICES (UNITED STATES), followed by MARCAN PHARMACEUTICALS INC. and TEVA PHARMACEUTICALS USA, INC.

How Does Intas Pharmaceuticals Limited Compare to Nearest Diltiazem Exporters?

Exporters ranked immediately above and below #4 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	MAIVA PHARMA PRIVATE LIMITED	$2.3M	47	1	$49.3K
3	PIRAMAL PHARMA LIMITED	$1.9M	37	2	$50.0K
4	INTAS PHARMACEUTICALS LIMITED ★	$1.3M	26	1	$50.0K
5	MYLAN LABORATORIES LIMITED	$1.2M	29	1	$43.1K
8	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$670.4K	28	3	$23.9K

Intas Pharmaceuticals Limited ranks #4 among 184 Indian Diltiazem exporters. Average shipment value of $50.0K compared to the market average of $78.0K. The closest competitors by value are MAIVA PHARMA PRIVATE LIMITED and PIRAMAL PHARMA LIMITED.

Which Indian Ports Ship Diltiazem Exports?

Port	Shipments	% Share
SAHAR AIR	357	19.6%
SAHAR AIR CARGO ACC (INBOM4)	302	16.6%
DELHI AIR CARGO ACC (INDEL4)	201	11.0%
NHAVA SHEVA SEA (INNSA1)	181	9.9%
DELHI AIR	155	8.5%
Bombay Air	100	5.5%
JNPT/ NHAVA SHEVA SEA	52	2.9%
Delhi Air	36	2.0%

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Diltiazem Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)

Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Diltiazem shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 71+ countries, 298+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Diltiazem

Diltiazem

Intas Pharmaceuticals Limited — Diltiazem Exporter Profile

Intas Pharmaceuticals Limited — Diltiazem Export Profile: Buyers & Destinations

Where Does India Export Diltiazem?

Who Are the Top Buyers of Diltiazem from India?

What Is India's Total Diltiazem Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Diltiazem Exports?

How Does Intas Pharmaceuticals Limited Compare to Other Indian Diltiazem Exporters?

Regulatory Requirements: Exporting Diltiazem to Key Markets

United States — FDA

Canada — HC

How Does Intas Pharmaceuticals Limited Compare to Nearest Diltiazem Exporters?

Which Indian Ports Ship Diltiazem Exports?

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Diltiazem Exports

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Intas Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Diltiazem Export Data from Intas Pharmaceuticals Limited

Diltiazem Stats

Company Overview

Top Products by Intas Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source